Earlier, FT reported that the European Medicines Agency (EMA) intended to begin checking the standards for conducting clinical trials of the Russian vaccine over fears that the trials in Russia were non-compliant with ethical standards.

​It is noted that the Sputnik V team had invited the EMA to conduct a rolling review of the registration dossier and was showing full transparency.